146 related articles for article (PubMed ID: 15179031)
41. PTH-related protein upregulates integrin alpha6beta4 expression and activates Akt in breast cancer cells.
Shen X; Falzon M
Exp Cell Res; 2006 Nov; 312(19):3822-34. PubMed ID: 16965770
[TBL] [Abstract][Full Text] [Related]
42. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
[TBL] [Abstract][Full Text] [Related]
43. miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells.
Cascio S; D'Andrea A; Ferla R; Surmacz E; Gulotta E; Amodeo V; Bazan V; Gebbia N; Russo A
J Cell Physiol; 2010 Jul; 224(1):242-9. PubMed ID: 20232316
[TBL] [Abstract][Full Text] [Related]
44. Association of the tetraspanin CD151 with the laminin-binding integrins alpha3beta1, alpha6beta1, alpha6beta4 and alpha7beta1 in cells in culture and in vivo.
Sterk LM; Geuijen CA; van den Berg JG; Claessen N; Weening JJ; Sonnenberg A
J Cell Sci; 2002 Mar; 115(Pt 6):1161-73. PubMed ID: 11884516
[TBL] [Abstract][Full Text] [Related]
45. Endothelin-2 is a hypoxia-induced autocrine survival factor for breast tumor cells.
Grimshaw MJ; Naylor S; Balkwill FR
Mol Cancer Ther; 2002 Dec; 1(14):1273-81. PubMed ID: 12516960
[TBL] [Abstract][Full Text] [Related]
46. The metastatic odyssey: the integrin connection.
Mercurio AM; Bachelder RE; Rabinovitz I; O'Connor KL; Tani T; Shaw LM
Surg Oncol Clin N Am; 2001 Apr; 10(2):313-28, viii-ix. PubMed ID: 11382589
[TBL] [Abstract][Full Text] [Related]
47. BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin.
Mayerhofer M; Valent P; Sperr WR; Griffin JD; Sillaber C
Blood; 2002 Nov; 100(10):3767-75. PubMed ID: 12393646
[TBL] [Abstract][Full Text] [Related]
48. Mobilization and activation of a signaling competent alpha6beta4integrin underlies its contribution to carcinoma progression.
Lipscomb EA; Mercurio AM
Cancer Metastasis Rev; 2005 Sep; 24(3):413-23. PubMed ID: 16258729
[TBL] [Abstract][Full Text] [Related]
49. Mnk mediates integrin α6β4-dependent eIF4E phosphorylation and translation of VEGF mRNA.
Korneeva NL; Soung YH; Kim HI; Giordano A; Rhoads RE; Gram H; Chung J
Mol Cancer Res; 2010 Dec; 8(12):1571-8. PubMed ID: 21047768
[TBL] [Abstract][Full Text] [Related]
50. Adhesion-independent alpha6beta4 integrin clustering is mediated by phosphatidylinositol 3-kinase.
Gilcrease MZ; Zhou X; Welch K
Cancer Res; 2004 Oct; 64(20):7395-8. PubMed ID: 15492261
[TBL] [Abstract][Full Text] [Related]
51. Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin.
Chen M; Sinha M; Luxon BA; Bresnick AR; O'Connor KL
J Biol Chem; 2009 Jan; 284(3):1484-94. PubMed ID: 19011242
[TBL] [Abstract][Full Text] [Related]
52. Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling.
Skinner HD; Zheng JZ; Fang J; Agani F; Jiang BH
J Biol Chem; 2004 Oct; 279(44):45643-51. PubMed ID: 15337760
[TBL] [Abstract][Full Text] [Related]
53. Laminin-binding integrins induce Dll4 expression and Notch signaling in endothelial cells.
Estrach S; Cailleteau L; Franco CA; Gerhardt H; Stefani C; Lemichez E; Gagnoux-Palacios L; Meneguzzi G; Mettouchi A
Circ Res; 2011 Jul; 109(2):172-82. PubMed ID: 21474814
[TBL] [Abstract][Full Text] [Related]
54. Suppression of anoikis in human intestinal epithelial cells: differentiation state-selective roles of α2β1, α3β1, α5β1, and α6β4 integrins.
Beauséjour M; Thibodeau S; Demers MJ; Bouchard V; Gauthier R; Beaulieu JF; Vachon PH
BMC Cell Biol; 2013 Dec; 14():53. PubMed ID: 24289209
[TBL] [Abstract][Full Text] [Related]
55. Multiple regulatory pathways of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in tumors.
Mukhopadhyay D; Datta K
Semin Cancer Biol; 2004 Apr; 14(2):123-30. PubMed ID: 15018896
[TBL] [Abstract][Full Text] [Related]
56. Integrin alpha6beta4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells.
Chen M; O'Connor KL
Oncogene; 2005 Jul; 24(32):5125-30. PubMed ID: 15897878
[TBL] [Abstract][Full Text] [Related]
57. NRP-1 interacts with GIPC1 and α6/β4-integrins to increase YAP1/∆Np63α-dependent epidermal cancer stem cell survival.
Grun D; Adhikary G; Eckert RL
Oncogene; 2018 Aug; 37(34):4711-4722. PubMed ID: 29755126
[TBL] [Abstract][Full Text] [Related]
58. Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines.
Blancher C; Moore JW; Talks KL; Houlbrook S; Harris AL
Cancer Res; 2000 Dec; 60(24):7106-13. PubMed ID: 11156418
[TBL] [Abstract][Full Text] [Related]
59. Activation of p53 function in carcinoma cells by the alpha6beta4 integrin.
Bachelder RE; Marchetti A; Falcioni R; Soddu S; Mercurio AM
J Biol Chem; 1999 Jul; 274(29):20733-7. PubMed ID: 10400708
[TBL] [Abstract][Full Text] [Related]
60. Crosstalk between integrin and receptor tyrosine kinase signaling in breast carcinoma progression.
Soung YH; Clifford JL; Chung J
BMB Rep; 2010 May; 43(5):311-8. PubMed ID: 20510013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
